Health experts are of the stance that, the emanation of brand-new strains of Covid-19 in Africa, have resulted to a rise in the counts of cases of Covid-19 and loss of lives that were accounted in many nations in Sub-Saharan Africa.

In recent months, there has been a second wave of the pandemic, in at least forty-40 African countries, inclusive of all the countries in the southern African region, this notion, was stated by the Africa Centre for Disease Control (CDC). The emerging second wave of the Covid-19 pandemic, is believed to be linked with the occurrence of novel strains of the Covid-19, these new variants, are more transmissible . According to the World Health Organization (W.H.O), in recent months, a new strain of the Corona virus disease arrived in South Africa and this variant has led to an upsurge in the accounted numbers of cases, in the Sub-Saharan Africa.

In other parts of the African continent, this new mutation of the Corona virus disease, has been officially accounted for in Tanzania, Mozambique, Zambia, Botswana, Kenya, Comoros and Ghana; there exists the probability of the new strain of Covid-19 virus reaching other countries on the African continent, however, most countries in Africa, do not have the much required monetary requirements and well trained health workers, that are needed to perform extremely specialized positioning of the D.N.A, required to map out and distinguish the new mutations of the Corona virus disease.

According to the W.H.O, in just confirmed medical laboratory diagnostic virology, results have indicated that, the Corona virus disease strain of the virus in South Africa is extremely transmissible amongst people. Recently, in just concluded research conducted by the University of Witwatersrand, the Oxford-Astra Zeneca Covid-19 vaccine, the first Corona virus vaccine that arrived in South Africa, provides minimal cure against modest and placid cases of Corona virus disease, that arose from the new strains of the Corona Virus. The just concluded research carried out by the University of Witwatersrand, did not focus on the vaccine's potency, in inhibiting harsh Corona virus disease infections. The Oxford-AstraZeneca Covid-19 vaccine, is a vaccine that was produced by a joint venture agreement between the University of Oxford and AstraZeneca Plc; AstraZeneca Plc, is a British-Swedish international pharmaceutical and biotechnology company, that has its headquarters situated at the University of Cambridge Biomedical Campus, in Cambridge England.

As of this moment, there is an urgent and pressing need, for individuals, banks, insurance companies, financial institutions, hedge funds, corporate organizations, mining companies, venture capitalists, international donors and philanthropists, to give aid to the efforts of health workers and doctors, across the African continent, that are working without rest to obliterate the Corona virus disease and ascertain that the Corona virus is totally cured for the health of Africans and the continent of Africa as a whole.

Doctors are of the creed that, the materialization of novel mutations of Corona virus in Southern African Region, have resulted to an upsurge in the number of cases of Covid-19 and deaths that were documented inside many countries in Sub-Saharan Africa.

There has been another wave of the global pandemic, in at least forty-40 African nations, inclusive of all the countries in the southern African region, this position, was stated by the Africa Centre for Disease Control (CDC). The occurring second wave of the Corona virus disease pandemic, is believed to be associated with the arrival of novel variants of the Corona virus, these new variants, are more virulent . According to the World Health Organization (W.H.O), in recent months, a new variant of the virus emerged in South Africa and this mutant has led to an increase in the accounted numbers of cases, in the southern African region.

In other areas of the African continent, this novel strain of the Corona virus disease, has been officially accounted for in Tanzania, Mozambique, Zambia, Botswana, Kenya, Comoros and Ghana; there exists the possibility of the new variant of Corona virus reaching other countries on the African continent, however, most countries in Africa, are bereft of the much needed financial requirements and well trained health staff, that are required to conduct very technical sequencing of the D.N.A, needed to discover and pinpoint the novel strains of the Corona virus disease.

According to the W.H.O, in recently conducted medical laboratory diagnostic test, results have indicated that, the Corona virus variant of the virus in South Africa is very transmissible amongst the citizens. Recently, in just concluded study carried out by the University of Witwatersrand, the Oxford-Astra Zeneca Corona virus vaccine, the first Corona virus vaccine that landed in South Africa, offers little panacea against clement and mellow cases of Corona Virus, that manifested from the new mutants of the Corona virus disease. The recent study carried out by the University of Witwatersrand, did not study the vaccine's efficacy, in stopping dangerous Corona virus disease contaminations. The Oxford-AstraZeneca Covid-19 vaccine, is a vaccine that was manufactured by a joint venture partnership between the University of Oxford and AstraZeneca Plc; AstraZeneca Plc, is a British-Swedish multinational pharmaceutical and biotechnology corporation, that has its headquarters located at the University of Cambridge Biomedical Campus, in Cambridge England.

Currently, there is an immediate and pressing demand, for individuals, banks, insurance companies, financial institutions, hedge funds, corporate organizations, mining companies, venture capitalists, international donors and philanthropists, to offer assistance to the efforts of health professionals and health experts, across the continent of Africa, that are working tirelessly to extirpate the Corona Virus and make sure that the Corona Virus is totally rooted out for the wellbeing of people of Africa and the African continent in its entirety.